Clinical and histopathological spectrum of IgA nephropathy in Kuwait

被引:6
|
作者
Ghani, Amal Abdel [1 ]
Al Waheeb, Salah [2 ]
Al Homoud, Ekhlas [3 ]
Al Helal, Bassam [1 ]
Hussain, Naser [1 ]
机构
[1] Mubarak Al Kabeer Hosp, Minist Hlth, Dept Nephrol Unit, Hawally, Kuwait
[2] Mubarak Al Kabeer Hosp, Minist Hlth, Dept Histopathol, Hawally, Kuwait
[3] Mubarak Al Kabeer Hosp, Minist Hlth, Dept Internal Med, Hawally, Kuwait
关键词
IMMUNOGLOBULIN-A NEPHROPATHY; URIC-ACID; PROTEINURIA; PROGNOSIS; THERAPY; FEATURES; CHILDREN; ADULTS; TRIAL;
D O I
10.4103/0256-4947.77491
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Little is known about the nature and the course of IgA nephropathy (IgAN) in Arab countries. The aim of this work was to study the spectrum of clinical presentation and histopathological findings at our institution. DESIGN AND SETTING: Retrospective review, all renal biopsies at the Mubarak Al Kabeer Hospital between January 2000 and December 2004. METHODS: Cases of IgAN were selected, and their medical records and biopsy findings were reviewed. RESULTS: Eighty patients (9.2% of all native kidney biopsies) were diagnosed to have IgAN. Sixty-nine biopsies were included in the study; 11 were excluded. Forty-three (62.3%) patients were male and 26 (37.7) patients were female. Fifty (72.5%) patients were below the age of 40 years. Mean (SD) duration of follow-up was 3.6 (1.3) years. The first presentation included nephritic-range proteinuria (49.3%) and renal impairment (50.7%). During the follow-up period, 56 (81.2%) patients were stable or improved. Hass classification of biopsies showed 36.2% had class I, 27.5% had class II, 13.0% had class III, 5.8% had class IV, and 17.4% had class V IgAN. Females had milder forms of the disease than males. Macroscopic hematuria and renal impairment at presentation were seen more in patients with class IV and V IgAN. The presenting serum creatinine and uric acid values were higher in those with Hass classes III to V. Deterioration of renal function during the follow-up period was more significant in the presence of hypertension, renal impairment, or macroscopic hematuria at the time of biopsy. CONCLUSION: The prevalence of IgAN in Kuwait is about 9.2% of native kidney biopsies. Renal impairment or macroscopic hematuria at presentation was seen in patients with more aggressive renal lesions and contributed to poor outcome.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 50 条
  • [31] Clinical outcomes of IgA nephropathy patients with different proportions of crescents
    Zhang, Wang
    Zhou, Qian
    Hong, Lingyao
    Chen, Wenfang
    Yang, Shicong
    Yang, Qiongqiong
    Chen, Wei
    Yu, Xueqing
    MEDICINE, 2017, 96 (11)
  • [32] Diagnosis and treatment of IgA nephropathy and IgA vasculitis nephritis in Chinese children
    Zhong, Xuhui
    Ding, Jie
    PEDIATRIC NEPHROLOGY, 2023, 38 (06) : 1707 - 1715
  • [33] Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
    Coppo, Rosanna
    Troyanov, Stephan
    Bellur, Shubha
    Cattran, Daniel
    Cook, H. Terence
    Feehally, John
    Roberts, Ian S. D.
    Morando, Laura
    Camilla, Roberta
    Tesar, Vladimir
    Lunberg, Sigrid
    Gesualdo, Loreto
    Emma, Francesco
    Rollino, Cristiana
    Amore, Alessandro
    Praga, Manuel
    Feriozzi, Sandro
    Segoloni, Giuseppe
    Pani, Antonello
    Cancarini, Giovanni
    Durlik, Magalena
    Moggia, Elisabetta
    Mazzucco, Gianna
    Giannakakis, Costantinos
    Honsova, Eva
    Sundelin, B. Brigitta
    Di Palma, Anna Maria
    Ferrario, Franco
    Gutierrez, Eduardo
    Asunis, Anna Maria
    Barratt, Jonathan
    Tardanico, Regina
    Perkowska-Ptasinska, Agnieszka
    KIDNEY INTERNATIONAL, 2014, 86 (04) : 828 - 836
  • [34] Comparison of clinical and pathological features of secondary IgA nephropathy of ankylosing spondylitis and primary IgA nephropathy
    Zhang, Guangli
    Tian, Zebo
    Xue, Qin
    CLINICAL NEPHROLOGY, 2022, 97 (05) : 273 - 280
  • [35] IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis
    Vivarelli, Marina
    Samuel, Susan
    Coppo, Rosanna
    Barratt, Jonathan
    Bonilla-Felix, Melvin
    Haffner, Dieter
    Gibson, Keisha
    Haas, Mark
    Abdel-Hafez, Maher Ahmed
    Adragna, Marta
    Brogan, Paul
    Kim, Siah
    Liu, Isaac
    Liu, Zhi-Hong
    Mantan, Mukta
    Shima, Yuko
    Shimuzu, Masaki
    Shen, Qian
    Trimarchi, Hernan
    Hahn, Deirdre
    Hodson, Elisabeth
    Pfister, Ken
    Alladin, Areefa
    Boyer, Olivia
    Nakanishi, Koichi
    Int Pediat Nephrology Assoc
    PEDIATRIC NEPHROLOGY, 2025, 40 (02) : 533 - 569
  • [36] Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients
    Coppo, Rosanna
    JOURNAL OF NEPHROLOGY, 2017, 30 (03) : 339 - 346
  • [37] Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
    Bagchi, Soumita
    Mani, Kalaivani
    Swamy, Anitha
    Barwad, Adarsh
    Singh, Geetika
    Bhowmik, Dipankar
    Agarwal, Sanjay Kumar
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (06): : 1661 - 1668
  • [38] Prognostic relevance of clinical and histological features in IgA nephropathy treated with steroid and angiotensin receptor blockers
    Choi, S.
    Lee, D.
    Jeong, K. -H.
    Moon, J. -Y.
    Lee, S. H.
    Lee, T. -W.
    Ihm, C. -G.
    CLINICAL NEPHROLOGY, 2009, 72 (05) : 353 - 359
  • [39] Rapamyciin Slows IgA Nephropathy Progression in the Rat
    Tian, Jihua
    Wang, Yanhong
    Zhou, Xiaoshuang
    Li, Yanjiao
    Wang, Chen
    Li, Jiaming
    Li, Rongshan
    AMERICAN JOURNAL OF NEPHROLOGY, 2014, 39 (03) : 218 - 229
  • [40] Development and validation of a prognostic nomogram for IgA nephropathy
    Liu, Jian
    Duan, Shuwei
    Chen, Pu
    Cai, Guangyan
    Wang, Yong
    Tang, Li
    Liu, Shuwen
    Zhou, Jianhui
    Wu, Di
    Shen, Wanjun
    Chen, Xiangmei
    Wu, Jie
    ONCOTARGET, 2017, 8 (55) : 94371 - 94381